This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "LITESPARK-013 Study Subgroup Analysis - Belzutifan in Advanced ccRCC"

95 views
June 10, 2024

Chapters

Belzutifan & Advanced Renal Cell Carcinoma

00:00

LITESPARK-013 Study Design & Demographics

01:56

Subgroup Efficacy Analysis Results

04:03

Conclusions & Future Research Directions

08:47

Comments 0
Login to view comments. Click here to Login